Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study.
Xin JiangYong-Jian ZhuYu-Ping ZhouFu-Hua PengLan WangWei MaYun-Shan CaoXin PanGang-Cheng ZhangFeng ZhangFen-Ling FanBing-Xiang WuWei HuangZhen-Wen YangCheng HongMeng-Tao LiYi-Ning WangXi-Qi XuDuo-Lao WangShu-Yang ZhangZhi-Cheng JingPublished in: European heart journal (2022)
Patients with TA-PH were predominantly female and had severely compromised haemodynamics. More than 80% of patients in our cohort survived for at least 3 years. Medical treatment was based on investigators' personal opinions, and no clear risk-to-benefit ratio can be derived from the presented data.
Keyphrases
- pulmonary hypertension
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- prognostic factors
- peritoneal dialysis
- pulmonary artery
- electronic health record
- pulmonary arterial hypertension
- machine learning
- big data
- combination therapy
- coronary artery
- deep learning
- free survival
- patient reported